Mikhail Kolosov

595 total citations
21 papers, 498 citations indexed

About

Mikhail Kolosov is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Mikhail Kolosov has authored 21 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Mikhail Kolosov's work include Cytokine Signaling Pathways and Interactions (10 papers), Tuberculosis Research and Epidemiology (3 papers) and Immune Response and Inflammation (3 papers). Mikhail Kolosov is often cited by papers focused on Cytokine Signaling Pathways and Interactions (10 papers), Tuberculosis Research and Epidemiology (3 papers) and Immune Response and Inflammation (3 papers). Mikhail Kolosov collaborates with scholars based in United States, Russia and China. Mikhail Kolosov's co-authors include Raj Kishore, Thomas A. Hamilton, Julie Tebo, David J. Tweardy, Moses M. Kasembeli, T. Kris Eckols, Uddalak Bharadwaj, Judy C. Chang, Lacey E. Dobrolecki and Jennifer Major and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Blood.

In The Last Decade

Mikhail Kolosov

21 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mikhail Kolosov United States 10 224 169 143 76 60 21 498
Ailian Xiong United States 11 264 1.2× 223 1.3× 95 0.7× 46 0.6× 65 1.1× 14 544
Young Ju Yoon South Korea 4 266 1.2× 142 0.8× 51 0.4× 54 0.7× 34 0.6× 4 428
Yun Sun Park South Korea 10 134 0.6× 168 1.0× 133 0.9× 69 0.9× 26 0.4× 17 402
Łukasz Sędek Poland 16 306 1.4× 113 0.7× 114 0.8× 37 0.5× 55 0.9× 59 771
Dominique Fokan Belgium 10 228 1.0× 93 0.6× 144 1.0× 55 0.7× 20 0.3× 11 502
Lingyuan Xu China 9 180 0.8× 159 0.9× 40 0.3× 44 0.6× 46 0.8× 11 397
Songmin Jiang China 14 292 1.3× 68 0.4× 63 0.4× 34 0.4× 40 0.7× 21 463
Chuanke Zhao China 14 364 1.6× 117 0.7× 60 0.4× 49 0.6× 34 0.6× 38 578
Jung-Chen Su Taiwan 17 435 1.9× 245 1.4× 118 0.8× 31 0.4× 67 1.1× 26 699
Mark Wade United States 13 314 1.4× 150 0.9× 98 0.7× 25 0.3× 28 0.5× 35 632

Countries citing papers authored by Mikhail Kolosov

Since Specialization
Citations

This map shows the geographic impact of Mikhail Kolosov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikhail Kolosov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikhail Kolosov more than expected).

Fields of papers citing papers by Mikhail Kolosov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikhail Kolosov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikhail Kolosov. The network helps show where Mikhail Kolosov may publish in the future.

Co-authorship network of co-authors of Mikhail Kolosov

This figure shows the co-authorship network connecting the top 25 collaborators of Mikhail Kolosov. A scholar is included among the top collaborators of Mikhail Kolosov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikhail Kolosov. Mikhail Kolosov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kong, Ren, Uddalak Bharadwaj, T. Kris Eckols, et al.. (2021). Novel STAT3 small-molecule inhibitors identified by structure-based virtual ligand screening incorporating SH2 domain flexibility. Pharmacological Research. 169. 105637–105637. 14 indexed citations
2.
Wang, Haopei, Alexandra M. Stevens, Michael Krueger, et al.. (2020). Targeting STAT3 anti-apoptosis pathways with organic and hybrid organic–inorganic inhibitors. Organic & Biomolecular Chemistry. 18(17). 3288–3296. 11 indexed citations
3.
Kolosov, Mikhail, et al.. (2020). Training in psychohygiene techniques in the system of development of military personnel sanogenic thinking. KANT. 35(2). 254–258. 1 indexed citations
4.
Kong, Ren, Uddalak Bharadwaj, T. Kris Eckols, et al.. (2019). Abstract 17: Novel STAT3 inhibitors identified by Structure-Based Virtual Ligand Screening incorporating SH2 domain flexibility. 17–17. 1 indexed citations
5.
Liu, Wei, Farrukh Vohidov, Moses M. Kasembeli, et al.. (2015). Rhodium(II) Proximity‐Labeling Identifies a Novel Target Site on STAT3 for Inhibitors with Potent Anti‐Leukemia Activity. Angewandte Chemie International Edition. 54(44). 13085–13089. 31 indexed citations
6.
Lewis, Katherine, Uddalak Bharadwaj, T. Kris Eckols, et al.. (2015). Small-molecule targeting of signal transducer and activator of transcription (STAT) 3 to treat non-small cell lung cancer. Lung Cancer. 90(2). 182–190. 46 indexed citations
7.
Liu, Wei, Farrukh Vohidov, Moses M. Kasembeli, et al.. (2015). Rhodium(II) Proximity‐Labeling Identifies a Novel Target Site on STAT3 for Inhibitors with Potent Anti‐Leukemia Activity. Angewandte Chemie. 127(44). 13277–13281. 8 indexed citations
8.
Krueger, Michael, Wei Liu, Alexandra M. Stevens, et al.. (2015). A Novel STAT3 Inhibitor Has Potent Activity in Preclinical Models of Acute Myeloid Leukemia That Incorporate the Stromal Environment. Blood. 126(23). 569–569. 4 indexed citations
9.
Bharadwaj, Uddalak, T. Kris Eckols, Mikhail Kolosov, et al.. (2014). Drug-repositioning screening identified piperlongumine as a direct STAT3 inhibitor with potent activity against breast cancer. Oncogene. 34(11). 1341–1353. 137 indexed citations
10.
Kolosov, Mikhail, et al.. (2014). Synthetic and Biological Studies of Phaeosphaerides. The Journal of Organic Chemistry. 79(9). 4043–4054. 24 indexed citations
11.
Bharadwaj, Uddalak, Moses M. Kasembeli, T. Kris Eckols, et al.. (2014). Monoclonal Antibodies Specific for STAT3β Reveal Its Contribution to Constitutive STAT3 Phosphorylation in Breast Cancer. Cancers. 6(4). 2012–2034. 16 indexed citations
12.
Tebo, Julie, Shyamasree Datta, Raj Kishore, et al.. (2000). Interleukin-1-mediated Stabilization of Mouse KC mRNA Depends on Sequences in both 5′- and 3′-Untranslated Regions. Journal of Biological Chemistry. 275(17). 12987–12993. 60 indexed citations
13.
Kishore, Raj, Julie Tebo, Mikhail Kolosov, & Thomas A. Hamilton. (1999). Cutting Edge: Clustered AU-Rich Elements Are the Target of IL-10-Mediated mRNA Destabilization in Mouse Macrophages. The Journal of Immunology. 162(5). 2457–2461. 83 indexed citations
14.
Alexandrov, Andrei, Irina Kolosova, & Mikhail Kolosov. (1996). mRNA stabilization in continuous flow translation system.. PubMed. 38(6). 1111–6. 1 indexed citations
15.
Kolosov, Mikhail, et al.. (1996). Autocrine Induction of Macrophage Synthesis of Complement Subcomponent Clq by Endogenous Interferon-α/β. Journal of Interferon & Cytokine Research. 16(3). 209–215. 7 indexed citations
16.
Jiang, Hong, et al.. (1996). IFN-α β reconstitutes the deficiency in lipid A-activated AKR macrophages for nitric oxide synthase. The Journal of Immunology. 157(1). 305–312. 6 indexed citations
18.
Kolosov, Mikhail, et al.. (1996). Stimulation of Macrophage Synthesis of Complement Clq by Interferon-γ Mediated by Endogenous Interferon-α/β. Journal of Interferon & Cytokine Research. 16(3). 245–249. 8 indexed citations
19.
Chen, Zhi, Hong Jiang, Mikhail Kolosov, et al.. (1995). Exogenous Interferon-γ Induces Endogenous Synthesis of Interferon-α and -β by Murine Macrophages for Induction of Nitric Oxide Synthase. Journal of Interferon & Cytokine Research. 15(10). 897–904. 27 indexed citations
20.
Alakhov, Valery Yu., Mikhail Kolosov, Ingrid Maurer-Fogy, et al.. (1992). Identification of functionally active fragments of staphylococcal enterotoxin B. European Journal of Biochemistry. 209(3). 823–828. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026